标题
Acute promyelocytic leukemia current treatment algorithms
作者
关键词
-
出版物
Blood Cancer Journal
Volume 11, Issue 6, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-06-30
DOI
10.1038/s41408-021-00514-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
- (2019) Miguel A. Sanz et al. BLOOD
- Oral arsenic trioxide incorporation into frontline treatment with all‐trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5‐year prospective study
- (2019) Harinder Gill et al. CANCER
- Unrecognized fluid overload during induction therapy increases morbidity in patients with acute promyelocytic leukemia
- (2019) Kamal Chamoun et al. CANCER
- Oral arsenic trioxide ORH-2014 pharmacokinetic and safety profile in patients with advanced hematologic disorders
- (2019) Farhad Ravandi et al. HAEMATOLOGICA
- Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial
- (2019) Laura Cicconi et al. LEUKEMIA
- Current and emerging treatments for acute promyelocytic leukemia
- (2019) Musa Yilmaz et al. Expert Opinion on Orphan Drugs
- Oral arsenic and all-transretinoic acid for high-risk acute promyelocytic leukemia
- (2018) Hong-Hu Zhu et al. BLOOD
- Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial
- (2018) Hong-Hu Zhu et al. LANCET ONCOLOGY
- Multicenter randomized trial of arsenic trioxide and Realgar-Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: interim results of the SCCLG-APL clinical study
- (2018) Ming-Hua Yang et al. AMERICAN JOURNAL OF HEMATOLOGY
- Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
- (2017) Uwe Platzbecker et al. JOURNAL OF CLINICAL ONCOLOGY
- Current management of newly diagnosed acute promyelocytic leukemia
- (2016) L. Cicconi et al. ANNALS OF ONCOLOGY
- Long-term outcome of acute promyelocytic leukemia treated with all- trans -retinoic acid, arsenic trioxide, and gemtuzumab
- (2016) Yasmin Abaza et al. BLOOD
- Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-transretinoic acid and arsenic trioxide
- (2015) David Sanford et al. BRITISH JOURNAL OF HAEMATOLOGY
- Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group
- (2015) Thorsten Braun et al. CANCER
- Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial
- (2015) Alan K Burnett et al. LANCET ONCOLOGY
- Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial
- (2015) Harry J Iland et al. Lancet Haematology
- How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia
- (2014) M. A. Sanz et al. BLOOD
- Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy
- (2014) Steven E. Coutre et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis
- (2014) Naval Daver et al. BRITISH JOURNAL OF HAEMATOLOGY
- Oral Arsenic and Retinoic Acid for Non–High-Risk Acute Promyelocytic Leukemia
- (2014) Hong-Hu Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia
- (2013) Akihiro Tomita et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Oral Tetra-Arsenic Tetra-Sulfide Formula Versus Intravenous Arsenic Trioxide As First-Line Treatment of Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trial
- (2013) Hong-Hu Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
- (2013) Francesco Lo-Coco et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute promyelocytic leukemia: A population-based study on incidence and survival in the United States, 1975-2008
- (2012) Yiming Chen et al. CANCER
- Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid
- (2011) J. H. Park et al. BLOOD
- AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance
- (2011) G. Avvisati et al. BLOOD
- The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia
- (2011) Karen A. Breen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phase II Study of Single-Agent Arsenic Trioxide for the Front-Line Therapy of Acute Promyelocytic Leukemia
- (2011) Ardeshir Ghavamzadeh et al. JOURNAL OF CLINICAL ONCOLOGY
- Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry
- (2011) S Lehmann et al. LEUKEMIA
- Outcome of therapy-related acute promyelocytic leukemia with or without arsenic trioxide as a component of frontline therapy
- (2010) Farshid Dayyani et al. CANCER
- Differentiation therapy of leukemia: 3 decades of development
- (2009) D. Nowak et al. BLOOD
- Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy
- (2008) W.-Y. Au et al. BLOOD
- Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group
- (2008) M. A. Sanz et al. BLOOD
- Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors
- (2008) P. Montesinos et al. BLOOD
- Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin
- (2008) Farhad Ravandi et al. JOURNAL OF CLINICAL ONCOLOGY
- Entry of elemental arsenic into the central nervous system in patients with acute promyelocytic leukemia during arsenic trioxide treatment
- (2007) Wing-Yan Au et al. LEUKEMIA RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now